Unknown

Dataset Information

0

Effect of Immunotherapy on Late Elderly Patients With Unresectable Hepatocellular Carcinoma: A Real‐World Clinical Study

ABSTRACT:

SUBMITTER: Kaneko S 

PROVIDER: S-EPMC12378699 | biostudies-literature | 2025 Aug

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown FOLFOX-HAIC combined with targeted immunotherapy for initially unresectable hepatocellular carcinoma: a real-world study.
| S-EPMC11628521 | biostudies-literature
Unknown Real-World Use of Immunotherapy for Hepatocellular Carcinoma.
| S-EPMC10455985 | biostudies-literature
Unknown Initial Experience of Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma in Real-World Clinical Practice.
| S-EPMC8199943 | biostudies-literature
Unknown Real-world effectiveness of lenvatinib monotherapy in previously treated unresectable hepatocellular carcinoma in US clinical practice.
| S-EPMC9875657 | biostudies-literature
Unknown Long-Term Survival of Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib in Real-World Clinical Practice.
| S-EPMC11816230 | biostudies-literature
Unknown Real-Life Clinical Data of Cabozantinib for Unresectable Hepatocellular Carcinoma.
| S-EPMC8339460 | biostudies-literature
Unknown Regorafenib combined with transarterial chemoembolization for unresectable hepatocellular carcinoma: a real-world study.
| S-EPMC8529854 | biostudies-literature
Unknown Immunotherapy for advanced hepatocellular carcinoma: From clinical trials to real-world data and future advances.
| S-EPMC9244967 | biostudies-literature
Unknown Prognostic factor of lenvatinib for unresectable hepatocellular carcinoma in real-world conditions-Multicenter analysis.
| S-EPMC6639201 | biostudies-literature
Unknown Real world study on combining local interventions with systemic therapy in unresectable hepatocellular carcinoma.
| S-EPMC11794854 | biostudies-literature